MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.62M | -75.89M | -36.40M | -55.81M | -66.97M |
| Total Depreciation and Amortization | 7.17M | 7.52M | 7.57M | 7.47M | 7.54M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.74M | -15.26M | -12.57M | -10.59M | -10.34M |
| Change in Net Operating Assets | -28.33M | -78.84M | -30.72M | -10.69M | 1.39M |
| Cash from Operations | -81.04M | -162.47M | -72.12M | -69.62M | -68.37M |
| Capital Expenditure | -1.91M | -2.29M | -2.46M | -2.78M | -3.71M |
| Sale of Property, Plant, and Equipment | 11.00K | 0.00 | 80.00K | 160.00K | 160.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -112.19M | -4.35M | 51.71M | 137.02M | 152.84M |
| Cash from Investing | -114.10M | -6.64M | 49.33M | 134.41M | 149.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 129.00K | 225.00K | 231.00K | 796.00K | 3.44M |
| Repurchase of Common Stock | -288.00K | -286.00K | -360.00K | -366.00K | -2.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 69.67M | 69.67M | 69.67M | -- | -- |
| Cash from Financing | 69.51M | 69.61M | 69.54M | 430.00K | 960.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.62M | -99.50M | 46.75M | 65.22M | 81.88M |